Clinical Trial Update: Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

A completed study compared the effects of aspirin versus SGLT2 inhibitors on liver enzymes, lipid profile, and FibroScan findings in individuals with Type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)
• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: Galala University | Conditions: Diabete Type 2, Non Alcoholic Fatty Liver | NA | Status: COMPLETED